Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Gains from Investment Securities (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Gains from Investment Securities for 15 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 100.64% to $4000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 52.9% year-over-year, with the annual reading at $569042.0 for FY2025, 72.76% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $4000.0 at Anika Therapeutics, up from $2000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $1.8 million in Q2 2025, with the low at -$3.4 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is -$15889.5, with a median of $4000.0 recorded in 2025.
  • The sharpest move saw Gains from Investment Securities crashed 183.13% in 2021, then surged 54900.0% in 2023.
  • Over 5 years, Gains from Investment Securities stood at -$1.4 million in 2021, then soared by 41.45% to -$829000.0 in 2022, then skyrocketed by 215.56% to $958000.0 in 2023, then plummeted by 165.03% to -$623000.0 in 2024, then surged by 100.64% to $4000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $4000.0, $2000.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.